Polyendocrine metabolic ovarian syndrome (PMOS) is a common hormonal disorder affecting women during their reproductive years ...

A maternal-fetal medicine expert told Newsweek the findings warrant study, but pregnant women shouldn't stop medications.

In a novel analysis examining the economic implications of generic semaglutide entering the Canadian market, researchers ...

Lucknow: India’s first once-weekly long-acting insulin, Awiqli (insulin icodec) was launched in Lucknow on Saturday and is ...

When writer Jasmin Griffin started to get odd notifications on her Instagram account, she discovered her name and pictures ...

India has approved QDENGA, its first dengue vaccine. A pulmonary specialist explains who should get vaccinated, who should ...

Researchers found no significant association between chronotype and FibroScan-derived liver fat or stiffness in 119 ...

WOMEN with polyendocrine metabolic ovarian syndrome (PMOS) face a four times higher risk of heart disease than those without ...

A review article by a University of Nebraska Medical Center/Child Health Research Institute research team underscores how altering fundamental brain development processes can harm the developing fetus ...

Biologic exposure for psoriasis is not associated with an increased rate of adverse pregnancy outcomes when compared with ...

Medically reviewed by Jamie Johnson, RDN Key Takeaways Many things can affect your blood sugar, not just the carbs you ...

GLP-1s are, without doubt, the hottest topic in women's health right now. Whether you're pro or sceptic (and it's clear that most people are one or the other), there's so much noise around the jabs ...